Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ruxolitinib therapy to Avoid Ventilation and improve outcome for deteriorating COVID-19 patients (RAVEN)
2020-001777-71Phase 4Unknown
- Sponsor
- Guy's and St Thomas' NHS Foundation Trust
- Start
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of ruxolitinib in coronavirus disease 2019 (COVID-19), sponsored by Guy's and St Thomas' NHS Foundation Trust. Primary endpoint: Progression to mechanical ventilation or death by day 28. Status: unknown.
02
Drugs
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on 2020-001777-71.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-001777-71.